Erratum
for
Nabholtz et al., J Clin Oncol 21 (6) 968-975.
Journal of Clinical Oncology, Vol 21, Issue 10
(May), 2003: 2048
© 2003 American Society for Clinical Oncology
ERRATUM
The March 15, 2003 article by Nabholtz et al entitled, "Docetaxel and Doxorubicin Compared With Doxorubicin and Cyclophosphamide as First-Line Chemotherapy for Metastatic Breast Cancer: Results of a Randomized, Multicenter, Phase III Trial" (J Clin Oncol 21:968–975, 2003) contained incorrect information in Table 2 and the References section.
The corrected table and reference are reprinted below in their entirety.
27. Jassem J, Pienkowski T, Pluzanska A, et al: Doxorubicin and Paclitaxel Versus Fluorouracil, Doxorubicin, and Cyclophosphamide as First-Line Therapy for Women With Metastatic Breast Cancer: Final Results of a Randomized Phase III Multicenter Trial. J Clin Oncol 19:1707–1715, 2001[Abstract/Free Full Text]
|
